Authors: Boyle, CD Chackalamannil, S Clader, JW Greenlee, WJ Josien, HB Kaminski, JJ Kozlowski, JA McCombie, SW Nazareno, DV Tagat, JR Wang, YG Zhou, GW Billard, W Binch, H Crosby, G Cohen-Williams, M Coffin, VL Cox, KA Grotz, DE Duffy, RA Ruperto, V Lachowicz, JE

Citation: Cd. Boyle et al., Metabolic stabilization of benzylidene ketal M-2 muscarinic receptor antagonists via halonaphthoic acid substitution, BIOORG MED, 11(17), 2001, pp. 2311-2314

Authors: Strizki, JM Xu, S Wagner, NE Wojcik, L Liu, J Hou, Y Endres, M Palani, A Shapiro, S Clader, JW Greenlee, WJ Tagat, JR McCombie, S Cox, K Fawzi, AB Chou, CC Pugliese-Sivo, C Davies, L Moreno, ME Ho, DD Trkola, A Stoddart, CA Moore, JP Reyes, GR Baroudy, BM

Citation: Jm. Strizki et al., SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo, P NAS US, 98(22), 2001, pp. 12718-12723

Authors: Palani, A Shapiro, S Clader, JW Greenlee, WJ Cox, K Strizki, J Endres, M Baroudy, BM

Citation: A. Palani et al., Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyll-1 '-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4 '-methyl-1,4 '-bipiperidine N-oxide (SCH 351125):An orally bioavailable human CCR5 antagonist for the treatment of HIV infection, J MED CHEM, 44(21), 2001, pp. 3339-3342

Authors: Wang, YG Chackalamannil, S Hu, ZY Clader, JW Greenlee, W Billard, W Binch, H Crosby, G Ruperto, V Duffy, RA McQuade, R Lachowicz, JE

Citation: Yg. Wang et al., Design and synthesis of piperidinyl piperidine analogues as potent and selective M-2 muscarinic receptor antagonists, BIOORG MED, 10(20), 2000, pp. 2247-2250

Authors: Billard, W Binch, H Bratzler, K Chen, LY Crosby, G Duffy, RA Dugar, S Lachowicz, J McQuade, R Pushpavanam, P Ruperto, VB Taylor, LA Clader, JW

Citation: W. Billard et al., Diphenylsulfone muscarinic antagonists: Piperidine derivatives with high M-2 selectivity and improved potency, BIOORG MED, 10(19), 2000, pp. 2209-2212